跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
UP-540
首页
药物
UP-540
UP-540
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Heat-clearing effervescence tablet for infants and its preparing method
申请人: GUIZHOU HONGQI PHARMACEUTICAL
优先权: 2005
CN
Nolvac viral coat protein with recombinant rod virus expression and its preparation
申请人: NAT MARINE ENVIROMENT MONITORI
优先权: 2004
CN
Rare earth up-conversion composite nano material for tumor treatment
申请人: UNIV FUJIAN MEDICAL
优先权: 2021
CN
Naltrexone long-acting sustained-release preparation with no need of coating and preparation method thereof
申请人: HAINAN PHOENIX INTERNAT DRUG R
优先权: 2009
CN
Lysosome-oriented luteolin carbon dots as well as preparation method and application thereof
申请人: UNIV HEFEI TECHNOLOGY
优先权: 2026
CN
药物
反馈